Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks

Efficiency in core processes is set to increase substantially due to AI. As we've all been told, artificial intelligence (AI) is going to disrupt everything in healthcare, from scheduling a doctor's appointment to developing new medicines. But there's a lot more to AI than large language models (LLMs) like ChatGPT. In fact, there's a good chance that AI's impact on biotech will go far beyond what consumer-facing AI applications might imply. Investors will accrue many of the benefits. Here's my predictions f ...